MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Medpace Holdings Inc

Gesloten

SectorGezondheidszorg

527.14 1.65

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

513.37

Max

528.78

Belangrijke statistieken

By Trading Economics

Inkomsten

-24M

90M

Verkoop

45M

603M

K/W

Sectorgemiddelde

39.212

36.442

Winstmarge

14.961

Werknemers

6,000

EBITDA

-2.8M

118M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-13.43% downside

Dividenden

By Dow Jones

Volgende Winsten

22 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

5.9B

15B

Vorige openingsprijs

525.49

Vorige sluitingsprijs

527.14

Nieuwssentiment

By Acuity

100%

0%

360 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Medpace Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 okt 2025, 21:10 UTC

Belangrijke Marktbewegers

Kezar Life Sciences Shares Surge After Break with FDA, Restructuring Plan

16 okt 2025, 19:03 UTC

Acquisities, Fusies, Overnames

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- 2nd Update

16 okt 2025, 17:58 UTC

Acquisities, Fusies, Overnames

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- Update

16 okt 2025, 17:12 UTC

Winsten

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record -- Update

16 okt 2025, 17:12 UTC

Acquisities, Fusies, Overnames

Canada Signals Limited Concern Over US Government Stakes in Canadian Miners

16 okt 2025, 16:59 UTC

Acquisities, Fusies, Overnames

Airbus's Takeover of Spirit AeroSystems Plants Gets French Antitrust Clearance

16 okt 2025, 23:44 UTC

Marktinformatie

Gold Climbs Amid Safe-Haven Demand -- Market Talk

16 okt 2025, 23:42 UTC

Marktinformatie

Nikkei May Fall, Tracking Wall Street's Declines -- Market Talk

16 okt 2025, 23:42 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 okt 2025, 22:15 UTC

Winsten

China Tower: Results Supported by Higher Contributions From Energy, Smart Tower Business >0788.HK

16 okt 2025, 22:15 UTC

Winsten

China Tower 9-Mos Rev CNY74.32B Vs. CNY72.45B >0788.HK

16 okt 2025, 22:15 UTC

Winsten

China Tower 9-Mos Net CNY8.71B Vs. Net CNY8.15B >0788.HK

16 okt 2025, 22:02 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 okt 2025, 22:02 UTC

Marktinformatie

Santos Drifts Into 'Oversold Territory' -- Market Talk

16 okt 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

16 okt 2025, 20:50 UTC

Marktinformatie
Winsten

Health Care Roundup: Market Talk

16 okt 2025, 20:23 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 okt 2025, 20:23 UTC

Marktinformatie

Recession Risks to Push Canada Toward October Rate Cut -- Market Talk

16 okt 2025, 20:20 UTC

Winsten

These Stocks Moved the Most Today: TSMC, Salesforce, HPE, F5, United Airlines, Travelers, J.B. Hunt, Praxis Precision, and More -- Barrons.com

16 okt 2025, 20:08 UTC

Acquisities, Fusies, Overnames

Jack in the Box to Sell Del Taco With Big Markdown. The Stock Plunged. -- Barrons.com

16 okt 2025, 19:37 UTC

Acquisities, Fusies, Overnames

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16 okt 2025, 19:26 UTC

Winsten

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 okt 2025, 19:24 UTC

Marktinformatie

U.S. Natural Gas Falls on Mild Weather, Ample Storage -- Market Talk

16 okt 2025, 19:23 UTC

Marktinformatie

Oil Falls As Oversupply Concerns Outweigh India News -- Market Talk

16 okt 2025, 19:23 UTC

Winsten

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 okt 2025, 18:35 UTC

Marktinformatie
Winsten

Charles Schwab Logs Another Quarter of Record Revenues, Earnings -- Market Talk

16 okt 2025, 18:31 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 okt 2025, 18:31 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 okt 2025, 18:31 UTC

Marktinformatie

Charles Schwab Readies Spot Crypto Trading -- Market Talk

16 okt 2025, 16:57 UTC

Marktinformatie

Oil Futures Lose Ground as EIA Reports Crude Stock Build -- Market Talk

Peer Vergelijking

Prijswijziging

Medpace Holdings Inc Prognose

Koersdoel

By TipRanks

-13.43% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 445.27 USD  -13.43%

Hoogste 531 USD

Laagste 305 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Medpace Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

12 ratings

2

Buy

7

Hold

3

Sell

Technische score

By Trading Central

300 / 302.88Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

360 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat